{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:06:12Z","timestamp":1786989972639,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["2011-0328"],"award-info":[{"award-number":["2011-0328"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010253","name":"Secretar\u00eda de Ciencia y T\u00e9cnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020150100012BA"],"award-info":[{"award-number":["20020150100012BA"]}],"id":[{"id":"10.13039\/501100010253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Productiva","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011758","name":"Ministrstvo za visoko \u0161olstvo, znanost in tehnologijo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011758","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["112 201501 00410"],"award-info":[{"award-number":["112 201501 00410"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.heliyon.2019.e01376","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T09:34:04Z","timestamp":1552988044000},"page":"e01376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Chalcone derivatives: synthesis, in\u00a0vitro and in\u00a0vivo evaluation of their anti-anxiety, anti-depression and analgesic effects"],"prefix":"10.1016","volume":"5","author":[{"given":"Josefina","family":"Higgs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Wasowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Juki\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Humberto","family":"Pav\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"de Tezanos Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Colettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Marder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2019.e01376_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/13543776.2014.995627","article-title":"Potential pharmacological uses of chalcones: a patent review (from June 2011 \u2013 2014)","volume":"25","author":"Matos","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.heliyon.2019.e01376_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","article-title":"A review of anti-infective and anti-inflammatory chalcones","volume":"42","author":"Nowakowska","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01376_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/12040896","article-title":"4\u2019-Acetamidochalcone derivatives as potential antinociceptive agents","volume":"12","author":"de Campos-Buzzi","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2019.e01376_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/14737167.6.5.591","article-title":"Economic burden of chronic pain","volume":"6","author":"Phillips","year":"2006","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.heliyon.2019.e01376_bib5","series-title":"Depression and Other Common Mental Disorders","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.heliyon.2019.e01376_bib6","series-title":"Pain Proporsal: Improving the Current and Future Management of Chronic Pain. A European Consensus Report","author":"Gustorff","year":"2010"},{"key":"10.1016\/j.heliyon.2019.e01376_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.heliyon.2019.e01376_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.lfs.2008.09.010","article-title":"Antinociceptive action of 4-methyl-5-trifluoromethyl-5-hydroxy-4, 5-dihydro-1H-pyrazole methyl ester in models of inflammatory pain in mice","volume":"83","author":"Milano","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2019.e01376_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/JEP.S23105","article-title":"Flavonoids as GABAA receptor ligands: the whole story?","volume":"4","author":"Marder","year":"2012","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.heliyon.2019.e01376_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.heliyon.2019.e01376_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2011.09.026","article-title":"Isoliquiritigenin, a chalcone compound, is a positive allosteric modulator of GABA A receptors and shows hypnotic effects","volume":"413","author":"Cho","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2019.e01376_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2013.04.020","article-title":"In\u00a0vitro binding affinities of a series of flavonoids for \u03bc-opioid receptors. Antinociceptive effect of the synthetic flavonoid 3,3-dibromoflavanone in mice","volume":"72","author":"Higgs","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2019.e01376_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1472-8206.2008.00639.x","article-title":"Evaluation of chalcones - a flavonoid subclass, for, their anxiolytic effects in rats using elevated plus maze and open field behaviour tests","volume":"22","author":"Jamal","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.pnpbp.2007.12.021","article-title":"Antidepressant-like effects of liquiritin and isoliquiritin from Glycyrrhiza uralensis in the forced swimming test and tail suspension test in mice","volume":"32","author":"Wang","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2019.e01376_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-0032-1333229","article-title":"Synthesis of 2,4-dihydroxychalcone derivatives as potential antidepressant effect","volume":"63","author":"Guan","year":"2013","journal-title":"Drug Res. (Stuttg)."},{"key":"10.1016\/j.heliyon.2019.e01376_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11064-013-1224-8","article-title":"Evaluation of potential antidepressant-like activity of chalcone-1203 in various murine experimental depressant models","volume":"39","author":"Guan","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.heliyon.2019.e01376_bib18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00044-011-9640-2","article-title":"Synthesis and studies on antidepressant activity of 2\u2032,4\u2032,6\u2032-trihydroxychalcone derivatives","volume":"21","author":"Sui","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.heliyon.2019.e01376_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/1521-4184(200110)334:10<332::AID-ARDP332>3.0.CO;2-O","article-title":"Antinociceptive properties of chalcones. Structure-activity relationships","volume":"334","author":"Corr\u00eaa","year":"2001","journal-title":"Arch. Der Pharm."},{"key":"10.1016\/j.heliyon.2019.e01376_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ardp.200600049","article-title":"Antinociceptive effects of synthetic chalcones obtained from xanthoxyline","volume":"339","author":"de Campos-Buzzi","year":"2006","journal-title":"Arch. der Pharm."},{"key":"10.1016\/j.heliyon.2019.e01376_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0223-5234(96)83978-X","article-title":"Synthesis of xanthoxyline derivatives with antinociceptive and antioedematogenic activities","volume":"31","author":"Cechinel-Filhol","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01376_bib22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1515\/znc-2008-11-1208","article-title":"Antinociceptive activity and preliminary structure-activity relationship of chalcone-like compounds","volume":"63","author":"Corr\u00eaa","year":"2008","journal-title":"Zeitschrift f\u00fcr Naturforschung. C, J. Biosci."},{"key":"10.1016\/j.heliyon.2019.e01376_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1078\/094471103321659924","article-title":"Analgesic and antiinflammatory effects of chalcones isolated from Myracrodruon urundeuva allem\u00e3o","volume":"10","author":"Viana","year":"2003","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2019.e01376_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2010.08.030","article-title":"Antinociceptive activity of a synthetic chalcone, flavokawin B on chemical and thermal models of nociception in mice","volume":"647","author":"Mohamad","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/jmf.2015.0092","article-title":"Chemical composition and antinociceptive potential of campomanesia reitziana fruits","volume":"19","author":"Angela","year":"2016","journal-title":"J. Med. Food."},{"key":"10.1016\/j.heliyon.2019.e01376_bib26","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/jm2016073","article-title":"A synthetic chalcone as a potent inducer of glutathione biosynthesis","volume":"55","author":"Kachadourian","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01376_bib27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.heliyon.2019.e01376_bib28","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/0006-2952(90)90716-X","article-title":"Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties","volume":"40","author":"Medina","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejphar.2017.11.048","article-title":"N-propyl-2,2-diphenyl-2-hydroxyacetamide, a novel \u03b1-hydroxyamide with anticonvulsant, anxiolytic and antidepressant-like effects that inhibits voltage-gated sodium channels","volume":"819","author":"Pastore","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0022-1759(84)90477-0","article-title":"Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens","volume":"67","author":"Landegren","year":"1984","journal-title":"J. lmmunol. Methods."},{"key":"10.1016\/j.heliyon.2019.e01376_bib31","series-title":"Absorption and Drug Development: Solubility, Permeability, and Charge State","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.heliyon.2019.e01376_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib34","first-page":"412","article-title":"Acetic acid analgesic screening, Fed","volume":"18","author":"Koster","year":"1959","journal-title":"Proc"},{"key":"10.1016\/j.heliyon.2019.e01376_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3959(91)90207-E","article-title":"Differentiating analgesic and non-analgesic drug activities on rat hot plate: effect of behavioral endpoint","volume":"47","author":"Carter","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.heliyon.2019.e01376_bib36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2006.04.004","article-title":"Central nervous system depressant action of flavonoid glycosides","volume":"539","author":"Fernandez","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1078\/0940-2993-00301","article-title":"Behavioral phenotyping of mice in pharmacological and toxicological research","volume":"55","author":"Karl","year":"2003","journal-title":"Exp. Toxicol. Pathol. Off. J. Gesellschaft F\u00fcr Toxikologische Pathol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0024-3205(81)90744-X","article-title":"High affinity renal [3H]flunitrazepam binding: characterization, localization, and alteration in hypertension","volume":"28","author":"Regan","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2019.e01376_bib39","first-page":"28","article-title":"Modulation of [3H] 8-OHDPAT binding to rat brain membranes by metal ions","volume":"50","author":"Arro","year":"2001","journal-title":"Proc. Est. Acad. Sci."},{"key":"10.1016\/j.heliyon.2019.e01376_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-3565(25)20932-6","article-title":"Mechanism of clocinnamox blockade of opioid receptors: evidence from in\u00a0vitro and ex\u00a0vivo binding and behavioral assays","volume":"279","author":"Zernig","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.heliyon.2019.e01376_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF02245961","article-title":"Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity","volume":"118","author":"Dawson","year":"1995","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1472-8206.2008.00639.x","article-title":"Evaluation of chalcones-a flavonoid subclass, for, their anxiolytic effects in rats using elevated plus maze and open field behaviour tests","volume":"22","author":"Jamal","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(01)00395-5","article-title":"Differential regulation of 5-HT 1A receptor-G protein interactions in brain following chronic antidepressant administration","volume":"26","author":"Hensler","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.heliyon.2019.e01376_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1471-4892(01)00116-3","article-title":"Serotonergic targets in depression","volume":"2","author":"Middlemiss","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01376_bib45","series-title":"Prog. Drug Res.","first-page":"103","article-title":"The 5-HT1A receptor and its ligands: structure and function","author":"Olivier","year":"1999"},{"key":"10.1016\/j.heliyon.2019.e01376_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0810as55","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","volume":"55","author":"Castagn\u00e9","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.heliyon.2019.e01376_bib47","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-3565(24)38982-7","article-title":"Improving the treatment of Schizophrenia\u202f: focus on serotonin (5-HT)1A receptors","volume":"295","author":"Millan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.heliyon.2019.e01376_bib48","first-page":"1","article-title":"Advanced research on the antidepressant effect of flavonoids","volume":"1","author":"Gong","year":"2014","journal-title":"Curr. Opin. Complement. Altern. Med."},{"key":"10.1016\/j.heliyon.2019.e01376_bib49","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/jm801590u","article-title":"Chalcones: a valid scaffold for monoamine oxidases inhibitors","volume":"52","author":"Chimenti","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01376_bib50","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/13543776.2011.596529","article-title":"Recent progress in therapeutic applications of chalcones","volume":"21","author":"Katsori","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.heliyon.2019.e01376_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1749-6632.2009.04904.x","article-title":"Evaluation of anti-inflammatory and analgesic activity of a novel rigid 3, 4-dihydroxy chalcone in mice","volume":"1171","author":"Heidari","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2019.e01376_bib52","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.ejmech.2008.09.002","article-title":"Synthesis and antinociceptive activities of some pyrazoline derivatives","volume":"44","author":"Kaplancikli","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01376_bib53","first-page":"541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"Neuro Rx J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.heliyon.2019.e01376_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844018367203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844018367203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:13:35Z","timestamp":1778883215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844018367203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2405844018367203"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01376","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chalcone derivatives: synthesis, in\u00a0vitro and in\u00a0vivo evaluation of their anti-anxiety, anti-depression and analgesic effects","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01376"}}